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Abstract  
Introduction: Despite accelerated measles control efforts, a massive measles resurgence occurred in the Democratic Republic of the Congo 
(DRC) starting in mid-2010, prompting an investigation into likely causes. Methods: We conducted a descriptive epidemiological analysis using 
measles immunization and surveillance data to understand the causes of the measles resurgence and to develop recommendations for elimination 
efforts in DRC. Results: During 2004-2012, performance indicator targets for case-based surveillance and routine measles vaccination were not 
met. Estimated coverage with the routine first dose of measles-containing vaccine (MCV1) increased from 57% to 73%. Phased supplementary 
immunization activities (SIAs) were conducted starting in 2002, in some cases with sub-optimal coverage (≤95%). In 2010, SIAs in five of 11 
provinces were not implemented as planned, resulting in a prolonged interval between SIAs, and a missed birth cohort in one province. During July 
1, 2010-December 30, 2012, high measles attack rates (>100 cases per 100,000 population) occurred in provinces that had estimated MCV1 
coverage lower than the national estimate and did not implement planned 2010 SIAs. The majority of confirmed case-patients were aged <10 
years (87%) and unvaccinated or with unknown vaccination status (75%). Surveillance detected two genotype B3 and one genotype B2 measles 
virus strains that were previously identified in the region.  Conclusion: The resurgence was likely caused by an accumulation of unvaccinated, 
measles-susceptible children due to low MCV1 coverage and suboptimal SIA implementation. To achieve the regional goal of measles elimination 
by 2020, efforts are needed in DRC to improve case-based surveillance and increase two-dose measles vaccination coverage through routine 
services and SIAs. 
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Measles is a highly-infectious and potentially fatal viral disease 
characterized by fever and rash. In 2012, measles caused an 
estimated 122,000 vaccine-preventable deaths worldwide [1]. 
Estimated measles vaccine effectiveness (VE) is 84% when 
administered at 9-11 months of age, and 93% when given at ≥12 
months of age [2]. Because >93%-95% population immunity is 
necessary to prevent measles epidemics, the World Health 
Organization (WHO) recommends all children receive two doses of 
measles vaccine [2, 3].  
In 2008, countries in the WHO African Region (AFR) adopted a 
measles pre-elimination goal to be achieved by the end of 2012 with 
the following targets: 1) >98% reduction in estimated regional 
measles mortality compared with 2000; 2) national measles 
incidence of <5 cases per 1,000,000 population per year; 3) >90% 
national coverage with the first dose of measles-containing vaccine 
(MCV1) and >80% MCV1 coverage in all districts; and 4) >95% 
coverage in all districts for MCV supplementary immunization 
activities (SIAs). Also included were surveillance performance 
targets of: 1) ≥2 cases of non-measles febrile rash illness per 
100,000 population; 2) ≥1 suspected measles case investigated 
with blood specimens in ≥80% of districts [4].  
  
In the Democratic Republic of the Congo (DRC), MCV1 given at 9 
months of age was introduced into the Expanded Programme on 
Immunization in 1977 [5]. The Reaching Every District (RED) 
approach to strengthening RI services was implemented beginning 
in 2003 [6]. To provide a second opportunity for measles 
vaccination, nationwide measles SIAs started in 2002, using a 
phased approach intended to cover the country every 3 years [7]. 
Integrated Disease Surveillance and Response (IDSR) was 
established in 2000 with aggregate reporting of 18 infectious 
diseases, including measles. Case-based surveillance with laboratory 
confirmation of suspected measles cases was established in 2003.  
  
In 2011, AFR countries adopted a goal for measles elimination by 
2020 [8]. However, starting in 2010 and continuing through 2014, 
DRC experienced the largest nationwide measles outbreak in AFR 
since the start of accelerated measles control efforts [9-12]. DRC is 
a key country for regional elimination efforts because of its large 
population, central location with nine international borders, and 
persistent reservoir of circulating measles viruses [9, 13]. We 
conducted a descriptive epidemiological analysis using immunization 
and surveillance data to understand the likely causes of the measles 





Study setting  
  
In 2012, DRC had an estimated population of 78.1 million persons, 
3.1 million live births, and 14.7 million children aged <5 years [14]. 
The DRC health system has 513 zones de santé (health districts) in 
11 provinces. Challenges for vaccination include a large target 
population, poorly accessible areas, complex logistics, a lack of 
government funding, weak health systems, civil unrest, and 
displaced persons [15-17]. The number of displaced persons peaked 
in 2013, with 2.9 million internally displaced persons (IDPs) in the 
eastern and northern provinces of DRC and 438,869 Congolese in 
other African countries [18-21]. The last population census was 
conducted in 1981 making estimation of the vaccination target 
population challenging.  
  
Measles immunization, 2002-2012  
  
To assess measles vaccination coverage in comparison with AFR 
indicator targets, we calculated MCV1 administrative coverage for 
2004-2012 at the national, provincial, and district levels by dividing 
the reported number of MCV1 doses administered by the number of 
targeted children aged <12 months, according to the DRC Ministry 
of Public Health (MOPH), multiplied by 100 (national target: >90%; 
district target: >80%). The number of districts reporting >80% 
MCV1 coverage was divided by the number of districts expected to 
report and multiplied by 100 (target: 100%) [22]. We reviewed 
WHO-United Nations Children's Fund (UNICEF) annual estimates of 
national MCV1 coverage among children aged <12 months, and 
population-based survey estimates of national and provincial MCV1 
coverage among children aged 12-23 months during 2004-2012 
[23-27]. We reviewed implementation dates, administrative 
coverage, and survey results from SIAs and outbreak response 
immunization (ORI) during 2002-2012; the AFR target of >95% SIA 
coverage in all districts could not be assessed due to unavailable 
data [22].  
  
Measles surveillance, 2004-2012  
  
Through IDSR, aggregate numbers of suspected measles cases and 
deaths were reported weekly from districts to the national level 
[28]. Through measles case-based surveillance, suspected measles 
cases were investigated using a case investigation form and 
laboratory testing of a blood specimen at the National Institute for 
Biomedical Research in Kinshasa [29]. Specimens were tested using 
standard enzyme-linked immunosorbent assays for measles-specific 
immunoglobulin M (IgM) antibodies; specimens with a negative or 
indeterminate result were tested for rubella-specific IgM (Enzygnost 
ELISATM, Siemens Healthcare Diagnostics Products, Marburg, 
Germany). A suspected measles case was defined as an illness with 
maculopapular rash and fever and one or more symptoms of cough, 
coryza, or conjunctivitis, or where a clinician suspects measles. A 
laboratory-confirmed measles case was defined as a suspected 
measles case with a positive laboratory test result for measles-
specific IgM in the absence of measles vaccination within 30 days of 
specimen collection. An epidemiologically-linked case was defined as 
a suspected measles case having contact (or living in the same 
district) with a laboratory-confirmed measles case whose rash onset 
was within the preceding 30 days. A clinically-compatible case was 
defined as a suspected measles case without a laboratory test result 
or established epidemiological link. We classified all laboratory-
confirmed, epidemiologically-linked, and clinically-compatible 
measles cases as confirmed measles cases.  
  
We analyzed de-duplicated IDSR and measles case-based 
surveillance data from 2004-2012. To assess case-based 
surveillance performance in comparison with AFR targets, we 
calculated two indicators as follows:1) the number of districts 
annually reporting ≥1 suspected measles case with a collected 
blood specimen divided by the number of districts expected to 
report (target: ≥80%); and 2) the number of suspected measles 
cases reported annually and "discarded" as non-measles because of 
a negative test result divided by the estimated population from DRC 
MOPH, multiplied by 100,000 (target: ≥2.0). Estimated annual 
measles incidence was calculated by dividing the number of 
suspected cases reported through IDSR by the estimated annual 
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Epidemiological description of the measles resurgence  
  
We conducted an epidemiological analysis of the resurgence period, 
defined as starting in the first month with a confirmed measles 
outbreak in 2010 and continuing through the end of 2012, using 
IDSR and case-based surveillance data from July 1, 2010-December 
31, 2012. A confirmed measles outbreak was defined as ≥3 
laboratory-confirmed cases occurring in a district in one month. We 
analyzed suspected measles cases and deaths reported through 
IDSR by date of rash onset, province, and district. Confirmed 
measles cases reported through case-based surveillance were 
analyzed by date of rash onset, age, vaccination status, province, 
and district. Cumulative measles attack rates were calculated by 
dividing the number of suspected cases reported through IDSR 
during the resurgence period, or a 6-month subset of the 
resurgence period, by the estimated 2012 population from DRC 
MOPH and multiplying by 100,000. Cumulative measles attack rates 
and confirmed measles outbreaks by district for 6-month periods 
were mapped. Analyses were conducted using Excel (Microsoft 
Corporation), SAS version 9.3 (SAS Institute), and ArcGIS (ESRI).  
  
To identify circulating measles virus strains, nasopharyngeal swabs 
were collected and tested at the National Institute for 
Communicable Diseases in South Africa. Ribonucleic acid (RNA) was 
extracted using the QIAamp® viral RNA mini kit (QIAGEN®) and 
amplified by reverse-transcriptase polymerase chain reaction. 
Amplicons were sequenced and analyzed using Sequencher software 
(Gene Codes Corporation 4.1.4, Ann Arbor, MI). Phylogenetic 
analysis of the viral nucleoprotein (N) gene relative to WHO measles 
reference strains was performed using the maximum likelihood 
algorithm of MEGA version 5.1 software with bootstrap test of 





Measles immunization, 2002-2012  
  
National MCV1 administrative coverage among children aged <12 
months increased from 64% to 89%, and WHO-UNICEF estimates 
of MCV1 coverage increased from 57% to 73% during 2004-2012. 
National MCV1 coverage among children aged 12-23 months 
estimated from surveys was 63% in 2007, 67% in 2010, and 75% 
in 2012. MCV1 coverage survey estimates were lower than reported 
administrative coverage for comparable years. In all years, MCV1 
administrative coverage varied substantially by province and was 
below the target of >90% at the national level and >80% in all 
districts (Table 1).  
  
A phased catch-up SIA targeting children aged 6 months-14 years 
was implemented during 2002-2006 (median reported 
administrative coverage by province: 96%; range: 73%-102%), and 
a phased follow-up SIA targeting children aged 6-59 months was 
completed during 2006-2010 (median reported administrative 
coverage: 99%; range: 92%-113%). A 4-year gap between these 
SIAs occurred in three provinces (Nord Kivu, Kasaï Oriental, and 
Bandundu). In 2009, another phased follow-up SIA was initiated in 
Nord Kivu (reported administrative coverage: 112%); however, the 
phase planned for 2010 was not implemented, leading to a 4-5 year 
gap between SIAs in five provinces (Kasaï Oriental, Kasaï 
Occidental, Katanga, Maniema, and Sud Kivu) and a missed cohort 
of children born in 2006 in Kasaï Oriental (Figure 1 and Table 2). 
After the start of the 2010 outbreaks, the entire country was 
covered by a combination of subnational measles follow-up SIAs 
and ORIs targeting children aged 6-59 months or 6 months-14 years 
during 2011-2012 (median reported administrative coverage: 101%; 
range: 93%-112%) (Figure 1 and Table 3).  
  
During 2002-2012, ≤95% administrative coverage was reported 
from ≥1 measles SIA in eight of 11 provinces (Figure 1). 
Availability of SIA coverage estimates from surveys during this 
period was limited. Coverage survey estimates for SIAs 
implemented in 2006, 2007 and 2011 were >95% in Kinshasa, 
Bandundu, Nord Kivu, and Maniema, and 94% in Kasaï Occidental, 
Katanga, and Maniema (Table 2, Table 3). Coverage survey 
estimates for ORIs implemented during 2010-2012 were >95% in 
Equateur, 92%-95% in Kasaï Occidental and two ORIs in Maniema, 
and 68% in Katanga (Table 3). In general, SIA and ORI coverage 
survey estimates were lower than reported administrative coverage 
(Table 2, Table 3).  
  
Measles surveillance, 2004-2012  
  
Measles case-based surveillance did not meet both annual 
performance indicator targets during 2004-2012. The number of 
suspected measles cases reported through case-based surveillance 
(16,789) was 3.6% of the total reported to IDSR (459,326); the 
number of suspected measles deaths reported through case-based 
surveillance (52) was 0.6% of the total reported to IDSR (8,400). 
Suspected measles incidence reported through IDSR did not meet 
the target of <5 per 1,000,000 population during 2004-2012. During 
2006-2009, incidence decreased 96%, from 1,164 to 47 per 
1,000,000. During 2010-2011, incidence increased from 73 to 1,769 
per 1,000,000, and was 935 per 1,000,000 in 2012 (Table 4).  
  
Epidemiological description of the measles resurgence  
  
During July 1, 2010-December 31, 2012, 211,236 suspected 
measles cases were reported through IDSR and 8,142 were 
reported through case-based surveillance. Of those reported 
through case-based surveillance, 4,252 (52%) were confirmed as 
measles (2,465 by laboratory testing and 1,787 by epidemiological 
link) and 866 (11%) were laboratory-confirmed as rubella (Figure 2 
and Table 4). Of the 4,250 confirmed measles cases with age 
information, 2,839 (67%) were among children aged <5 years, and 
879 (21%) were among children aged 5-9 years; 1,036 (24%) were 
among unvaccinated persons, and 2,168 (51%) were among 
persons with missing or unknown vaccination status (Table 5).  
  
The first confirmed measles outbreaks of 2010 were reported in 
three geographic foci: 1) Lemera district bordering Burundi in Sud 
Kivu province in July 2010; 2) Sakania district bordering Zambia in 
Katanga province in August 2010; and 3) Dilolo district bordering 
Angola in Katanga province in September 2010. During July-
December 2010, Sud Kivu and Katanga reported elevated 
cumulative measles attack rates and had 14 districts with confirmed 
outbreaks. In 2011, the epidemic peaked with confirmed measles 
outbreaks reported from 108 districts in all 11 provinces and the 
highest cumulative attack rates reported in Sud Kivu, Katanga, 
Maniema, and Kasaï Oriental provinces. In 2012, a second epidemic 
peak occurred with confirmed outbreaks reported from 126 districts 
in all 11 provinces and the highest cumulative attack rates reported 
from Province Orientale and Equateur (Figure 2, Figure 3 A and 
Figure 3 B).  
  
Measles virus genotype results were available from 47 confirmed 
measles cases in 13 (6%) of 218 districts that had a confirmed 
outbreak and 8 (73%) of 11 provinces. Three genetic groups of 
measles virus strains were detected each, associated with one of 
the three initial outbreak foci and thereafter clustered 
geographically. Of 47 measles viruses, 13 (28%) were from a group 
of B3.1 genotypic strains (B3-RwaAng) related to measles virus 
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previously detected in Rwanda and Angola; these strains were first 
detected in a Sud Kivu district bordering Burundi and localized to 
northeastern DRC during the outbreak. Another 20 (43%) were 
from a group of B3.1 genotypic strains (B3-ZamZimSA) related or 
identical to measles viruses detected during 2009-2011 in Zambia, 
Zimbabwe and South Africa [31, 32]; these strains were first 
detected in a Katanga district bordering Zambia and localized to 
southern and central DRC. Finally, 13 (28%) were from a group of 
B2 genotypic strains (B2-AngNamDRC) related to those previously 
detected in Angola, Namibia, and DRC [13]; these strains were first 
detected in a Katanga district bordering Angola and localized to 
southern DRC (Figure 3 B, and Figure 4). One district in Bas-
Congo province reported both B3-ZamZimSA and B2-AngNamDRC 
strains in the third-quarter of 2011 (Figure 3 B).  
 
During the resurgence period, the national cumulative attack rate 
based on IDSR reporting was 270 cases per 100,000 population. 
The provinces with high cumulative attack rates (>100 cases per 
100,000 population) were Katanga, Maniema, Kasaï Oriental, 
Province Orientale, Equateur, and Sud Kivu. Among these six 
provinces, estimated MCV1 coverage in the 2010 survey ranged 
from 46% to 66% (median: 54%), and four provinces had planned 
SIAs in 2010 that were not implemented. By contrast, estimated 
MCV1 coverage in the 2010 survey among the five provinces 
without high cumulative attack rates ranged from 49% to 91% 
(median 80%), and one province had a planned SIA in 2010 that 





Following accelerated measles control efforts and dramatic decrease 
in measles incidence, a massive measles resurgence occurred in 
DRC. The results of this study suggest the resurgence was likely 
caused by an accumulation of measles-susceptible children not 
vaccinated due to low RI coverage and suboptimal SIA 
implementation. Furthermore, detailed epidemiological analyses 
necessary for guiding timely outbreak response were limited by 
under-performing case-based surveillance.  
Despite implementation of the RED strategy and increasing MCV1 
coverage in DRC during 2004-2012, coverage remained far below 
WHO-recommended targets for monitoring progress toward measles 
elimination [9, 33]. Results from coverage surveys indicated 
challenges with the reliability of administrative coverage and 
highlighted the need to conduct surveys to monitor coverage. In 
countries where only a single routine dose of measles vaccine is 
provided, achieving high coverage through both RI and SIAs is 
necessary to reduce measles incidence [22].  
  
After implementation of the initial measles catch-up SIA during 
2002-2006, measles incidence in DRC decreased dramatically. 
However, the catch-up SIA and follow-up SIAs were implemented in 
a phased manner to accommodate logistical challenges and 
resource limitations. This phased approach to implementation left a 
gap of 4-5 years between SIAs in some provinces, as well as a 
missed birth cohort in one province, which likely allowed for 
sustained measles virus transmission, similar to what has recently 
occurred in other large AFR countries [9, 34-36].  
  
In DRC, widespread measles outbreaks continued during 2013-2014 
among children who were targeted by SIAs and ORIs during 2011-
2012. During 2013, 88,382 suspected and 1,321 confirmed cases 
were reported nationally, mostly from Province Orientale, Equateur 
and Kasaï Occidental; during 2014, 35,835 suspected and 1,643 
confirmed cases were reported nationally (DRC MOPH and WHO-
DRC unpublished data). Although administrative coverage from the 
2011-2012 campaigns was generally high (>92%), suboptimal 
coverage was estimated by surveys conducted after the 2012 ORI in 
Katanga (68%), and in districts with outbreaks after the 2011 SIAs 
in Equateur and Province Orientale (<50%) [11, 17]. Additionally, 
some SIAs and ORIs were delayed because of the amount of time it 
took to secure and disburse funds, and to complete the extensive 
planning and logistics needed to reach poorly-accessible areas.  
  
Although measles case-based surveillance with laboratory testing 
has been functional in DRC since 2003, performance indicators were 
unmet during 2004-2012, and challenges occurred with missing data 
(e.g. vaccination status). Surveillance guidelines specify that all 
suspected measles cases should be reported through measles case-
based surveillance; however, the number of suspected measles 
cases reported through case-based surveillance was <4% of IDSR-
reported cases [28]. This disparity was partly caused by the 
underutilization of measles case-based guidelines for the use of 
"line-lists" and the "epidemiologically-linked" case classification 
during confirmed outbreaks. These guidelines ensure that key 
epidemiological data, including age, vaccination status, and date of 
rash onset are collected for all cases, without requiring blood 
specimen collection and testing of all outbreak cases that might 
overburden the laboratory [29]. Case-based measles surveillance is 
a cornerstone of the measles elimination strategy; rapid case 
detection and laboratory confirmation is essential for rapid 
response, including effectively defining the target geographical area 
and age-group for SIAs and ORIs [37].  
  
During 2009-2010, the African region experienced a measles 
resurgence with 28 of 46 AFR countries reporting laboratory-
confirmed measles outbreaks, including large outbreaks in Burkina 
Faso, DRC, Ethiopia, Malawi, Nigeria, South Africa, Zambia, and 
Zimbabwe [9, 31, 32, 38, 39]. The regional resurgence was 
generally characterized by outbreaks with cases occurring among 
older children and young adults as a result of long-standing gaps in 
vaccination, combined with reduced risk of measles virus exposure 
due to decreased incidence since 2000 [9]. By contrast, 87% of 
measles cases during the resurgence in DRC occurred among 
children <10 years old, indicating persistent low population 
immunity among young children and on-going measles virus 
transmission. Virologic surveillance detected concurrent transmission 
of three separate measles virus strains in DRC; these strains were 
previously identified in neighboring countries, including a B3 strain 
detected in outbreaks throughout southern Africa during 2009-2011 
[32].  
  
During July 1, 2010-December 30, 2012, high measles attack rates 
occurred in provinces (Katanga, Maniema, Kasaï Oriental, Province 
Orientale, Equateur, and Sud Kivu) that had estimated MCV1 
coverage in the 2010 survey lower than the national estimate (67%) 
and did not implement planned 2010 SIAs. Kasaï Occidental 
province had a relatively low attack rate (68 cases per 100,000 
population) during 2010-2012 despite having 49% estimated MCV1 
coverage in the 2010 survey and not implementing a planned 2010 
SIA. The lower reported attack rate in Kasaï Occidental might have 
reflected underreporting from poor surveillance quality or a relative 
delay in the progression of the outbreak due to the northwest 
geographic spread of the outbreak over time from the initial foci in 
the south and east; in 2013, the measles attack rate in Kasaï 
Occidental increased to >100 cases per 100,000 population (DRC 
MOPH and WHO-DRC unpublished data). An additional factor that 
may have impacted relative attack rates among provinces during the 
measles outbreak was the increase in number of IDPs and refugees, 
as well as affected areas, during 2010-2013 [18-21]. There was 
some overlap between the provinces with high measles attack rates 
and those with large numbers of displaced persons; however, a 
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detailed analysis of the temporal and geographical relationship of 
these events was not performed.  
  
The study analyses had limitations. First, reported administrative 
coverage was likely overestimated due to unreliable denominators, 
as indicated by coverage >100% and lower coverage estimates by 
survey. Second, analysis of campaign quality was limited in part by 
the small number of coverage surveys conducted and lack of 
detailed post-campaign reports available. Not all available coverage 
surveys were performed using probability-based sampling methods, 
so representativeness of the estimates could not be determined. 
Third, under-reporting through case-based surveillance and the 
number of districts that were silent for IDSR reporting suggest 
measles incidence was likely underestimated. Fourth, because 
suspected measles cases reported through IDSR were not 
confirmed, some illnesses attributable to other causes of febrile 
rash, including rubella, were likely misclassified in IDSR as 





To achieve measles elimination in DRC, we recommended specific 
efforts to improve case-based surveillance and increase two-dose 
measles vaccination coverage. Realistic plans need to be developed 
to fully implement case-based surveillance, including adequate 
costing and resource mobilization for blood collection supplies, 
testing, and specimen transport. Periodic refresher trainings should 
be provided to ensure the implementation of measles case-based 
surveillance according to WHO guidelines [22, 29]. Additionally, 
WHO-recommended measles case-based surveillance performance 
indicators should be calculated monthly in a surveillance bulletin 
provided to all districts and used as a tool for supervision, 
management, and surveillance strengthening [29]. Measures to 
strengthen RI services are needed, including increased supportive 
supervision, human resources, and training, as well as improved 
micro-planning, vaccine management, and logistics. Because of 
suboptimal MCV1 coverage, periodic high-quality, nationwide SIAs 
should be implemented, ideally without phases and covering the 
entire country during a 4-7 day period; however, if a limitation in 
resources necessitates a phased approach, then the number of 
phases and the time needed to cover the entire country should be 
minimized [40]. SIA frequency and target age groups should be 
based on epidemiological analyses, and adequate resources made 
available to ensure optimal implementation [41]. According to WHO 
guidelines, SIA planning should start at least 6-8 months in 
advance, with close supervision and monitoring during 
implementation, and a post-campaign coverage survey [40]. To 
ensure timely outbreak response, a national measles outbreak 
preparedness plan is needed [37].  
 
During September 2013-August 2014, with funding and support 
from Gavi the Vaccine Alliance, WHO, UNICEF, and the Measles & 
Rubella Initiative, the DRC MOPH conducted a phased nationwide 
measles SIA targeting children aged 6 months-9 years, 
incorporating SIA best practices identified during a workshop in 
Kinshasa in April 2013, and post-campaign coverage surveys were 
completed in four provinces. The country will need to conduct the 
next follow-up SIA in 2016 and should begin the planning process in 
early 2015. To achieve measles elimination in AFR by 2020, 
additional commitments and resources will be needed to implement 
strategies for increasing two-dose vaccination coverage and 
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Tables and figures 
 
Table 1: coverage with the routine first dose of measles-containing 
vaccine by administrative reporting, survey, and WHO-UNICEF 
estimate during 2004-2012 and cumulative measles attack rates 
during July 1, 2010-December 31, 2012, Democratic Republic of the 
Congo  
Table 2: coverage from measles supplementary immunization 
activities (SIA) by administrative reporting and post-campaign 
surveys, Democratic Republic of the Congo, 2002-2010  
Table 3: coverage from measles supplementary immunization 
activities (SIA) during 2011-2012 and outbreak response 
immunization (ORI) during 2010-2012 by administrative reporting 
and post-campaign surveys, Democratic Republic of the Congo  
Table 4: measles surveillance data reported through Integrated 
Disease Surveillance and Response and measles case-based 
surveillance, Democratic Republic of the Congo, 2004-2012  
Table 5: confirmed measles cases+ reported through measles 
case-based surveillance by age group and measles vaccination 
status, Democratic Republic of the Congo, July 1, 2010-December 
31, 2012  
Figure 1: administrative measles vaccination coverage from 
supplementary immunization activities (SIA) and outbreak response 
immunization (ORI) by province and year during 2002-2012, and 
cumulative measles attack rates reported through Integrated 
Disease Surveillance and Response during July 1, 2010-December 
31, 2012, Democratic Republic of the Congo  
Figure 2: suspected measles cases reported through Integrated 
Disease Surveillance and Response and confirmed measles cases 
reported through case-based surveillance by week, Democratic 
Republic of the Congo, July 1, 2010-December 31, 2012 (+53 cases 
confirmed by epidemiologic-link and reported through outbreak line-
lists were missing date of rash onset)  
Figure 3: district maps of (A) cumulative measles attack rates 
reported through Integrated Disease Surveillance and Response and 
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(B) confirmed measles outbreaks and measles virus strains reported 
through case-based surveillance for 6-month periods, Democratic 
Republic of the Congo, July 1, 2010-December 31, 2012 (provinces: 
1. Province Orientale, 2. Nord Kivu, 3. Sud Kivu, 4. Maniema, 5. 
Katanga, 6. Kasaï Oriental, 7. Kasaï Occidental, 8. Bandundu, 9. 
Bas-Congo, 10. Kinshasa, and 11. Equateur; districts with first 
confirmed outbreaks: a. Lemera, b. Sakania, and c. Dilolo; each dot 
represents 1-8 viruses with the same genotype in a district within a 
month)  
Figure 4: phylogenetic analysis of the viral nucleoprotein gene of 
measles virus strains detected in the Democratic Republic of the 
Congo, July 1, 2010-February 28, 2012 (scale bar distance of 
0.005=2 nucleotides substitutions in the 450 nucleotide sequenced 
region; sequence names contain information on the sequence 
source, district, country, epidemiologic week, year, and sequential 
case number; Genbank accession numbers indicated in brackets; 
abbreviations: MVi, measles virus sequenced from isolates; MVs, 
measles virus sequenced from clinical specimens; COD, Democratic 
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Table 1: coverage with the routine first dose of measles-containing vaccine by administrative reporting, survey, and WHO-UNICEF estimate 
during 2004–2012 and cumulative measles attack rates during July 1, 2010–December 31, 2012, Democratic Republic of the Congo 
Province 
MCV1 administrative coverage (%)a 
MCV1 coverage 





























Katanga 66 76 79 74 83 88 91 89 91 52 66 72 774 
Maniema 48 81 69 85 82 87 92 96 97 45 46 67 543 
Kasaï Oriental 63 65 68 75 73 85 86 88 89 59 52 62 504 
Province Orientale 45 50 53 70 71 73 78 70 75 50 60 62 366 
Equateur 51 56 74 83 74 86 80 83 84 42 51 74 112 
Sud Kivu 50 63 76 104 84 87 94 93 96 84 57 86 107 
Bandundu 75 73 77 89 71 88 90 88 91 79 91 88 95 
Kasaï Occidental 65 73 73 71 82 94 93 80 104 45 49 54 68 
Bas-Congo 79 84 82 88 83 91 89 78 85 88 77 78 46 
Kinshasa 78 80 77 76 77 86 85 79 82 91 86 88 25 
Nord Kivu 86 95 81 80 78 91 93 98 94 86 80 88 13 
National 64 70 73 79 77 86 87 85 89 63 67 75 270 
National WHO-UNICEF 
estimatesd 
57 61 63 68 64 72 74 74 73 - - - - 
% of districts with 
MCV1 >80%e 
26 35 37 49 44 68 68 60 68 - - - - 
Abbreviations: MCV1=first dose of measles-containing vaccine, DHS=Demographic Health Survey, MICS=Multiple Indicator Cluster Survey, 
EPI=Expanded Programme on Immunization, Democratic Republic of the Congo, WHO=World Health Organization, UNICEF=United Nations 
Children's Fund, IDSR=Integrated Disease Surveillance and Response, MOPH=Ministry of Public Health 
a Calculated by dividing the number of MCV1 doses given by the targeted number of children <12 months of age and multiplying by 100; target 
>90% 
b Estimates from coverage surveys conducted among children aged 12–23 months of age [24–26] 
c Calculated by dividing the number of suspected cases reported to IDSR during July 1, 2010 to December 31, 2012 by the estimated 2012 
population from the MOPH and multiplying by 100; target >90% 
d Annual estimates of national MCV1 coverage for children <12 months of age [23]  
e Calculated by dividing the number of districts reporting >80% MCV1 coverage by the number of districts expected to report and multiplying by 



































































































Table 2: coverage from measles supplementary immunization activities by administrative reporting and post-campaign surveys, 
Democratic Republic of the Congo, 2002–2010 










Kasaï Oriental 2002 Dec. Catch-up 6m–14y 3,478,261 96 - 
Nord Kivu 2002 Dec. Catch-up 6m–14y 2,076,563 96 - 
Kasaï Occidental 2004 Oct.–Nov. Catch-up 6m–14y 2,473,668 88 - 
Katanga 2004 Oct.–Nov. Catch-up 6m–14y 3,784,714 87 - 
Maniema 2004 Oct.–Nov. Catch-up 6m–14y 768,987 102 - 
Sud Kivu 2004 Oct.–Nov. Catch-up 6m–14y 1,577,385 73 - 
Equateur 2005 Oct. Catch-up 6m–14y 3,268,004 87 - 
Province Orientale 2005 Oct. Catch-up 6m–14y 3,691,667 91 - 
Bas-Congo 2006 Dec. Catch-up 6m–14y 1,246,371 97 - 
Kinshasa 2006 Nov. Catch-up 6m–14y 2,659,229 97 
 
98d Bandundu 2006 Nov. Catch-up 6m–14y 3,064,629 101 
Nord Kivu 2006 Oct. Follow-up 6–59m 900,330 103 
Kasaï Oriental 2006 May Follow-up 6–59m 1,257,999 94 - 
Kasaï Occidental 2007 Aug.–Sep. Follow-up 6–59m 1,068,950 100 
 
94d Katanga 2007 Aug.–Sep. Follow-up 6–59m 1,624,002 99 
Maniema 2007 Sep. Follow-up 6–59m 290,803 97 
Sud-Kivu 2007 Sep. Follow-up 6–59m 821,937 113 - 
Equateur 2008 Nov. Follow-up 6–59m 1,449,659 103 - 
Province Orientale 2008 Nov. Follow-up 6–59m 1,361,433 94 - 
Bas-Congo 2009 Nov. Follow-up 6–59m 482,070 92 - 
Kinshasa 2009 Nov. Follow-up 6–59m 1,086,047 96 - 
Nord Kivu 2009 Nov. Follow-up 6–59m 1,073,437 112 - 
Bandundu 2010 Jan. Follow-up 6–59m 1,274,163 105 - 
Abbreviations: m=month, y=year, SIA=Supplementary Immunization Activity 
a “Catch-up” SIAs are one-time campaigns targeting a wide age range with the aim to quickly reduce measles susceptibility in the 
population. “Follow-up” SIAs are periodic campaigns targeting children born since the last SIA to reduce the accumulation of 
susceptible children 
b Calculated by dividing the number of measles vaccine doses administered by the targeted number of children and multiplying by 
100; target >95% 
c Estimates from coverage surveys conducted among children in the age group targeted 
d 2006 and 2007 survey coverage estimates are overall estimates for the three campaigns indicated 




Table 3: coverage from measles supplementary immunization activities during 2011–2012 and outbreak response immunization during 






















Bandundu 52 46 2012 Jan. Follow-up 6–59m 1,239,803 99 - 
  
 
6 2012 Jan. ORI 6–59m 129,000 102 - 
  
 
5 2012 Oct.–Nov. ORI 6m–14y 507,034 105 - 
Bas-Congo 31 5 2011 Jul. ORI 6–59m 65,657 99 - 
  
 
18 2012 Jan. Follow-up 6–59m 303,786 97 - 
  
 
9 2012 Jan. ORI 6m–14y 530,149 100 - 
  
 
1 2012 Oct. ORI 6m–14y 82,842 102 - 
Equateur 69 3 2011 Jul. ORI 6–59m 106,103 91 - 
  
 
66 2011 Sep. Follow-up 6–59m 1,419,411 94 - 
  
 
1 2012 Apr.–May ORI 6m–14y 128,752 108 - 
  
 
6 2012 Sep. ORI 6m–14y 477,066 94 96 
Kasaï 
Occidental 
44 1 2011 Jan.–Feb. ORI 6m–14y 123,045 93 - 
  
 
3 2011 Mar.–Apr. ORI 6m–14y 430,571 104 - 
  
 
9 2011 May ORI 6m–14y 792,389 111 - 
  
 
4 2011 Jul. ORI 6–59m 125,109 106 - 
  
 
29 2011 Jul. Follow-up 6–59m 684,176 98 - 
  
 
5 2012 Aug. ORI 6m–14y 348,176 104 94 
Kasaï Oriental 51 31 2011 Jul. Follow-up 6–59m 729,336 103 - 
  
 
4 2011 Mar.–Apr. ORI 6–59m 159,542 104 - 
  
 
14 2011 Apr. ORI 6–59m 564,252 99 - 
  
 
2 2011 Jun. ORI 6m–14y 268,586 99 - 
  
 
8 2012 Mar. ORI 6m–14y 478,588 104 - 
  
 
1 2012 Nov. ORI 6–59m 67,152 103 - 
Katanga 68 2 2010 Oct.–Dec. ORI 6m–14y 144,071 90 - 
  
 
27 2011 Jan.–Aug. ORI 6m–14y 1,847,096 102 d 
  
 
24 2011 May ORI 6m–14y 1,917,060 103 - 
  
 
17 2011 Jul. Follow-up 6–59m 585,633 105 - 
  
 
2 2011 Oct.–Dec. ORI 6m–14y 167,485 74 - 
  
 
10 2012 Aug. ORI 6m–14y 941,879 97 68 
Kinshasa  35 25 2011 Dec. Follow-up 6–59m 1,089,048 101 - 
  
 
10 2011 Dec. ORI 6m–14y 937,439 89 - 
Maniema 18 14 2011 May ORI 6m–14y 833,512 101 95 
  
 
4 2011 Jul. Follow-up 6–59m 58,202 103 98 
  
 
2 2012 Aug. ORI 6m–14y 81,247 96 94 
Nord Kivu 28 19 2012 Jan. Follow-up 6–59m 948,237 112 - 
  
 
5 2012 Jan. ORI 6–59m 284,592 107 - 
  
 
1 2012 Aug. ORI 6m–14y 197,820 116 - 
Province 
Orientale 
83 7 2011 Jul. ORI 6–59m 119,586 93 - 
  
 
1 2011 Sep. ORI 6m–14y 74,549 108 - 
  
 
76 2011 Sep. Follow-up 6–59m 1,456,498 96 - 
  
 
2 2012 Aug.–Nov. ORI 6m-14y 97,332 99 - 
Sud Kivu 34 1 2010 Nov.–Dec. ORI 6m–14y 88,853 100 - 
  
 
4 2011 Feb.–Jun. ORI 6m–14y 250,877 81 - 
  
 
25 2011 May ORI 6m–14y 1,826,722 102 - 
  
 
4 2011 Jul. Follow-up 6–59m 95,955 105 - 
Abbreviations: m=month, y=year, SIA=Supplementary Immunization Activity, ORI=Outbreak Response Immunization 
a “Follow-up” SIAs are periodic campaigns targeting children born since the last SIA to reduce the accumulation of susceptible children 
ORIs are campaigns conducted in response to confirmed outbreaks, with target age and geographic area based on epidemiology and 
available resources 
b Calculated by dividing the number of measles vaccine doses administered by the targeted number of children and multiplying by 100; 
target >95% 
c Estimates from coverage surveys conducted among children in the age group targeted 
d District-level coverage survey estimates available for campaigns conducted by MSF in 19 of 27 districts [12]  




Table 4: measles surveillance data reported through Integrated Disease Surveillance and Response and measles case-based 




Indicator 2004 2005 2006 2007 2008 2009 2010 2011 2012 Total 
IDSR 
          
No. suspected measles 
cases 
42,827 53,022 79,873 55,440 12,490 3,364 5,365 133,907 73,038 459,326 
No. suspected measles 
deaths 
1,097 595 1,181 1,463 247 73 82 1,650 2,012 8,400 
Suspected measles 
incidence per 1,000,000a 
640 782 1,164 823 180 47 73 1,769 935 6,412 
Case-based 
surveillance 
                    
No. suspected measles 
cases 
769 1,364 2,148 1,923 1,178 701 1,453 3,170 4,083 16,789 
No. confirmed measles 
cases 
387 429 780 543 219 44 190 1,824 2,248 6,664 
Lab-confirmed 382 407 780 468 213 44 188 1,077 1,209 4,768 
Confirmed by epi-link 2 10 - 73 - - 1 747 1,039 1,872 
Clinically compatible 3 12 - 2 6 - 1 - - 24 
No. lab-confirmed rubella 
cases 
61 122 205 244 231 101 199 291 452 1,906 
Districts with ≥1 
specimen (%)b 
20 43 56 56 48 41 46 57 65 - 
Non-measles febrile rash 
per 100,000c 
0.4 1.3 2.0 2.0 1.4 0.8 1.7 1.8 2.3 - 
Abbreviations: No.=number, IDSR=Integrated Disease Surveillance and Response, epi-link=epidemiological link, MOPH=Ministry of 
Public Health  
a  Calculated by dividing the number suspected measles cases reported annually by the estimated annual population from MOPH and 
multiplying by 1,000,000; target: <5 per 1,000,000 
b  Calculated by dividing the number of districts reporting ≥1 suspected measles case with a blood specimen collected in a year by 
the number of districts expected to report and multiplying by 100; target: ≥80% 
c  Calculated by dividing the number of suspected measles cases reported annually that were discarded as non-measles due to a 






Table 5: confirmed measles cases+ reported through measles case-based surveillance by age 
group and measles vaccination status, Democratic Republic of the Congo, July 1, 2010–
December 31, 2012 
 
Cases with 








Age group No. % No. % No. % No. % 
<9 months 39 3.7 151 53.9 90 32.1 280 6.6 
9–59 months 706 27.6 642 25.1 1,211 47.3 2,559 60.2 
5–9 years 212 24.1 149 17.0 518 58.9 879 20.7 
10–14 years 53 22.2 37 15.5 149 62.3 239 5.6 
≥15 years 36 12.3 57 19.5 200 68.3 293 6.9 
Total 1,046 24.6 1,036 24.4 2,168 51.0 4,250 100.0 
Abbreviations: MCV=measles-containing vaccine, No.=number 
+Confirmed cases were defined as all laboratory-confirmed, epidemiologically-linked, and 










Figure 1: administrative measles vaccination coverage from supplementary immunization 
activities (SIA) and outbreak response immunization (ORI) by province and year during 2002-
2012, and cumulative measles attack rates reported through Integrated Disease Surveillance 






Figure 2: suspected measles cases reported through Integrated Disease 
Surveillance and Response and confirmed measles cases reported through 
case-based surveillance by week, Democratic Republic of the Congo, July 1, 
2010-December 31, 2012 (+53 cases confirmed by epidemiologic-link and 
reported through outbreak line-lists were missing date of rash onset)  
 




Figure 3: district maps of (A) cumulative measles attack rates reported 
through Integrated Disease Surveillance and Response and (B) confirmed 
measles outbreaks and measles virus strains reported through case-based 
surveillance for 6-month periods, Democratic Republic of the Congo, July 1, 
2010-December 31, 2012 (provinces: 1. Province Orientale, 2. Nord Kivu, 3. 
Sud Kivu, 4. Maniema, 5. Katanga, 6. Kasaï Oriental, 7. Kasaï Occidental, 8. 
Bandundu, 9. Bas-Congo, 10. Kinshasa, and 11. Equateur; districts with first 
confirmed outbreaks: a. Lemera, b. Sakania, and c. Dilolo; each dot represents 
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Figure 4: phylogenetic analysis of the viral nucleoprotein gene of 
measles virus strains detected in the Democratic Republic of the Congo, 
July 1, 2010-February 28, 2012 (scale bar distance of 0.005=2 
nucleotides substitutions in the 450 nucleotide sequenced region; 
sequence names contain information on the sequence source, district, 
country, epidemiologic week, year, and sequential case number; Genbank 
accession numbers indicated in brackets; abbreviations: MVi, measles 
virus sequenced from isolates; MVs, measles virus sequenced from clinical 
specimens; COD, Democratic Republic of the Congo; GAB, Gabon; NGA, 
Nigeria; CAE, Cameroon) 
 
 
 
